Year 2019 / Volume 111 / Number 8
Original
The main determinants of disability in IBD and its relationship to optimism

579-585

DOI: 10.17235/reed.2019.6033/2018

Juliana M. Costa, Diana Matos, Bruno Arroja, Raquel Gonçalves, João B. Soares,

Abstract
Background and aim: inflammatory bowel disease (IBD) is a potentially disabling chronic disease that negatively affects many aspects of the patients’ life. This study aimed to assess the IBD-associated disability in the outpatient setting and analyze how optimism and disability are related. Methods: a cross-sectional study was performed via the application of the Portuguese version of the IBD-Disability Index (PT-IBD-DI) and the Revised Life Orientation Test (PT-LOT-R) for the assessment of disability and optimism, respectively. Results: a total of 143 patients were analyzed, the mean age was 38 ± 13 years, 50% were females and 51% had UC. The mean PT-IBD-DI score was 22 ± 17, which was classified as follows: 0-20: no disability; 20-35: mild disability; 35-50: moderate disability; and 50-100: severe disability. There were no significant differences between Crohn’s disease (CD) and ulcerative colitis (UC) (p = 0.944). Female gender (p = 0.001), low level of education (p = 0.018), the number of days out of work (p = 0.020), rheumatologic manifestations (p = 0.005), the number of comorbidities (p = 0.002), the use psychotropic drugs (p = 0.043) and low PT-LOT-R scores (p < 0.001) were associated with higher IBD-DI scores according to the univariate analysis. According to the linear regression analysis, only female sex (p = 0.001), the number of comorbidities (p = 0.034) and low PT-LOT-R scores (p < 0.001) were associated with higher PT-IBD-DI scores. Optimism correlated inversely with PT-IBD-DI scores (ρ = -0.345, p < 0.001). Conclusion: IBD outpatients reported low levels of IBD-disability (mild disability: PT-IBD-DI score 20-35). Comorbidities and psychological factors (optimism) emerged as the main predictive factors of increased disability, reinforcing the importance of a multidisciplinary approach for these patients.
Share Button
New comment
Comments
No comments for this article
References
(1) Casellas F, Lopez-Vivancos J, Vergara M et al. Impact of inflammatory bowel disease on health-related quality of life. Dig Dis 1999;17:208-18.
(2) Peyrin-Biroulet L. What is the patient's perspective: How important are patient-reported outcomes, quality of life and disability? Dig Dis 2010;28:463-71.
(3) Peyrin-Biroulet L, Cieza A, Sandborn WJ et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012;61:241-7.
(4) Gower-Rousseau C, Sarter H, Savoye G et al. Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort. Gut 2017;66:588-96.
(5) Soares JB, Pereira R, Costa JM et al. The Inflammatory Bowel Disease-Disability Index: validation of the Portuguese version according to the COSMIN checklist. Eur J Gastroenterol Hepatol 2016;28:1151-60.
(6) van der Have M, van der Aalst KS, Kaptein AA et al. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. J Crohns Colitis 2014;8:93-106.
(7) Berroa de la Rosa, Mora Cuadrado Natalia, Fernandez Salazar Luis. Las preocupaciones de los pacientes españoles con enfermedad inflamatoria intestinal medidas con el cuestionario RFIPC. Rev Esp Enferm Dig 2017;109 (3):196-201.
(8) Dür M, Sadloňová M, Haider S et al. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing. J Crohns Colitis 2014;8:45-55.
(9) Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. Pers Soc Psychol 1994;67:1063-78.
(10) Carver CS, Scheier MF. Dispositional optimism. Trends Cogn Sci 2014;18:293-9.
(11) Laranjeira CA. Portuguese Translation and Validation of the Revised Life Orientation Test. Univ Psychol 2008;7:469-76.
(12) Peyrin-Biroulet L, Sandborn W, Sands BE et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. Am J Gastroenterol 2015;110:1324-38.
(13) Leong RW, Huang T, Ko Y et al. Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis. J Crohns Colitis 2014;8:1237-45.
(14) van der Have M, Fidder HH, Leenders M et al. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions. Inflamm Bowel Dis 2015;21: 69-77.
(15) Williet N, Sarter H, Gower-Rousseau C et al. Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients. J Crohns Colitis 2017;11:165-74.
(16) Fernández O, Baumstarck-Barrau K, Simeoni MC, Auquier P; MusiQoL study group. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires. Mult Scler 2011;17:1238-49.
(17) Vlassoff C. Gender differences in determinants and consequences of health and illness. J Health Popul Nutr 2007;25:47-61.
(18) Boerma T, Hosseinpoor AR, Verdes E et al. A global assessment of the gender gap in self-reported health with survey data from 59 countries. BMC Public Health 2016;16:675.
Related articles

Letter

Hepatosplenic T-cell lymphoma and inflammatory bowel disease

DOI: 10.17235/reed.2023.9472/2023

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Apoptotic colopathy as a manifestation of Good’s syndrome

DOI: 10.17235/reed.2021.8297/2021

Original

Radon exposure and inflammatory bowel disease in a radon prone area

DOI: 10.17235/reed.2021.8239/2021

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Editorial

Is celiac disease really associated with inflammatory bowel disease?

DOI: 10.17235/reed.2019.6779/2019

Original

Megacolon in inflammatory bowel disease: response to infliximab

DOI: 10.17235/reed.2020.6394/2019

Editorial

Inflammatory bowel disease – Newer models of care

DOI: 10.17235/reed.2019.6495/2019

Editorial

Diet in the etiology of inflammatory bowel disease

DOI: 10.17235/reed.2018.6119/2018

Case Report

Serrated Lesions in patients with Inflammatory Bowel Disease.

DOI: 10.17235/reed.2019.5910/2018

Editorial

Online social networks and inflammatory bowel disease

DOI: 10.17235/reed.2018.5496/2018

Letter to the Editor

Idiopathic portal hypertension with regard to thiopurine treatment

DOI: 10.17235/reed.2018.5256/2017

Editorial

Specialist care in the management of inflammatory bowel disease

DOI: 10.17235/reed.2016.4628/2016

Citation tools
Costa J, Matos D, Arroja B, Gonçalves R, Soares J. The main determinants of disability in IBD and its relationship to optimism. 6033/2018


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 490 visits.
This article has been downloaded 231 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 07/11/2018

Accepted: 29/03/2019

Online First: 19/06/2019

Published: 31/07/2019

Article revision time: 136 days

Article Online First time: 224 days

Article editing time: 266 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology